BioSpace News Archive

Economic activity in the hospital subsector grew in May for the 12th consecutive month, say the nation’s hospital supply executives in the latest Hospital ISM® Report On Business®.

Lennham Pharmaceuticals today announced topline results of the first ever human study of d9-caffeine.

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Simoa® technology has been used in a worldwide collaborative study of the plasma neurofilament light (NfL) biomarker to evaluate its utility for a range of neurological conditions.

Enzolytics, Inc. has announced a coherent protocol that it intends to execute to meet the Company’s objective of producing a therapeutic cure for HIV as well as a planned protocol to address existing and future pandemics.

Seven and Eight Biopharmaceuticals Inc., announces the presentation of Phase 1 data for BDB001 in combination with pembrolizumab in advanced solid tumors at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

The market is estimated to grow with a CAGR of 15.7% from 2020-2027.

The report provides trends prevailing in the global mineral trioxide aggregate (MTA) market and the factors driving market along with those that act as hindrances.

The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth.

Today’s FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer’s disease reflects years of significant advances in Alzheimer’s research.

Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will participate in an analyst-led fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference